Oxford BioMedica Share Price (OXB)

4.00 +0.09 (+2.30%) delayed: 12:29PM GMT
Bid price 3.96 Open price 4.00
Ask price 4.04 Prev close 3.91
High price 4.10 Spread 1.98%
Low price 3.90 Volume 2,389,074

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 4.00 Net Gearing (%) 60.95
Market Capitalisation (£m) 121.05 Gross Gearing (%) 78.99
Shares in issue (m) 3,088.05 Debt Ratio 71.84
P/E Ratio -7.69 Debt-to-Equity Ratio 0.68
Total dividends per share (p) 0.00 Assets / Equity Ratio 4.76
Dividend Yield (%) 0.00 Price to book value 11.12
Dividend cover (x) 0.00 ROCE (%) -43.90
Earning per share (p) -0.51 EPS Growth (%) -18.60
52 week high / low 7.50 / 2.57 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
24/02/2017 BUY Dr Lorenzo Tallarigo CH 67,165
24/01/2017 BUY Martin Diggle NED 200,000
24/01/2017 BUY Martin Diggle NED 600,000
23/01/2017 BUY Martin Diggle NED 1,700,000
20/12/2016 LOF Dr Lorenzo Tallarigo CH 65,993

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

10:25 24/02/2017

Director Deals - Oxford BioMedica PLC (OXB)

Dr Lorenzo Tallarigo, Chairman, bought 67,165 shares in the company on the 23rd February 2017 at a price of 3.90p. The Director now holds 1,784,122 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

09:36 24/02/2017

Director Dealings

RNS Number : 7945X Oxford Biomedica PLC 24 February 2017     Director Dealings / Market Share Purchase   Oxford, UK - 24 February 2017:   Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE: OXB), a leading gene and cell therapy group,...

07:00 24/02/2017

Results of TroVax® in Advanced Colorectal Cancer

RNS Number : 7343X Oxford Biomedica PLC 24 February 2017   Oxford BioMedica Notes Encouraging Results of the Investigator Led Phase I/II clinical trial of MVA-5T4 Immunotherapy (TroVax®) and Low Dose Cyclophosphamide in Patients with Advanced Colorectal Cancer   ~ Both...

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

more than 1 year ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one. http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions